Published in Nutr Metab (Lond) on May 29, 2013
Caffeic acid derivatives inhibit the growth of colon cancer: involvement of the PI3-K/Akt and AMPK signaling pathways. PLoS One (2014) 0.91
Modulating DDAH/NOS Pathway to Discover Vasoprotective Insulin Sensitizers. J Diabetes Res (2015) 0.81
Neonatal Citrulline Supplementation and Later Exposure to a High Fructose Diet in Rats Born with a Low Birth Weight: A Preliminary Report. Nutrients (2017) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
The AMP-activated protein kinase--fuel gauge of the mammalian cell? Eur J Biochem (1997) 7.69
Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation (2006) 5.91
Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci U S A (1998) 4.94
Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem (2002) 4.54
Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci U S A (1991) 4.50
Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Physiol (1992) 3.26
L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood (2006) 3.17
Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem (1998) 2.92
Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels. J Clin Invest (2006) 2.52
Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci U S A (1997) 2.47
Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE/inducible NO synthase double-knockout mice. Arterioscler Thromb Vasc Biol (2003) 2.42
Explaining the phenomenon of nitrate tolerance. Circ Res (2005) 2.36
L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA (2006) 2.24
L-arginine supplementation in peripheral arterial disease: no benefit and possible harm. Circulation (2007) 1.97
Thrombin activates AMP-activated protein kinase in endothelial cells via a pathway involving Ca2+/calmodulin-dependent protein kinase kinase beta. Mol Cell Biol (2006) 1.88
The genes of hepatic glucose metabolism. J Biol Chem (1990) 1.83
Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. J Appl Physiol (1985) (2001) 1.76
Substrate-dependent regulation of intracellular amino acid concentrations in cultured bovine aortic endothelial cells. Biochem Biophys Res Commun (1990) 1.39
Role of nitric oxide in NMDA-evoked release of [3H]-dopamine from striatal slices. Neuroreport (1992) 1.29
Identification of nitric oxide as an endogenous activator of the AMP-activated protein kinase in vascular endothelial cells. J Biol Chem (2008) 1.25
AMP-activated protein kinase mediates VEGF-stimulated endothelial NO production. Biochem Biophys Res Commun (2007) 1.17
Atrial natriuretic peptide-initiated cGMP pathways regulate vasodilator-stimulated phosphoprotein phosphorylation and angiogenesis in vascular endothelium. J Biol Chem (2007) 1.15
The effect of peroxynitrite on the catalytic activity of soluble guanylyl cyclase. Free Radic Biol Med (2001) 1.14
Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway. Mol Pharmacol (2003) 1.11
Pharmacokinetics of intravenous and oral L-arginine in normal volunteers. Br J Clin Pharmacol (1999) 1.01
Simultaneous bioanalysis of L-arginine, L-citrulline, and dimethylarginines by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci (2011) 1.00
Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase. Br J Pharmacol (1999) 1.00
Fluid shear stress and NO decrease the activity of the hydroxy-methylglutaryl coenzyme A reductase in endothelial cells via the AMP-activated protein kinase and FoxO1. Circ Res (2007) 1.00
Bradykinin stimulates endothelial cell fatty acid oxidation by CaMKK-dependent activation of AMPK. Atherosclerosis (2008) 0.99
Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation. J Am Coll Cardiol (2000) 0.99
Galactose-1-phosphate in the pathophysiology of galactosemia. Eur J Pediatr (1995) 0.97
Effect of L-arginine on intestinal mucosal immune barrier function in weaned pigs after Escherichia coli LPS challenge. Innate Immun (2012) 0.95
Amino acids as modulators of endothelium-derived nitric oxide. Am J Physiol Renal Physiol (2006) 0.94
Nutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBar. Vasc Med (2000) 0.94
Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris. Am J Cardiol (1997) 0.89
Arginine in the critical care setting. J Nutr (2007) 0.89
Sodium nitroprusside inhibits N-methyl-D-aspartate-evoked calcium influx via a nitric oxide- and cGMP-independent mechanism. Mol Pharmacol (1992) 0.88
Efficacy and safety of oral l-arginine in acute myocardial infarction. Results of the multicenter, randomized, double-blind, placebo-controlled ARAMI pilot trial. Kardiol Pol (2005) 0.86
Continuous exposure to L-arginine induces oxidative stress and physiological tolerance in cultured human endothelial cells. Amino Acids (2011) 0.86
Partial deficiency of galactose-1-phosphate uridyltransferase. Eur J Pediatr (1995) 0.85
Mechanism of cellular oxidation stress induced by asymmetric dimethylarginine. Int J Mol Sci (2012) 0.84
Promising therapies in sickle cell disease. Cardiovasc Hematol Disord Drug Targets (2009) 0.84
A pilot study of L-arginine supplementation on functional capacity in peripheral arterial disease. Vasc Med (2005) 0.83
Effects of arginine supplementation on mucosal immunity in rats with septic peritonitis. Clin Nutr (2004) 0.82
Effects of L-NAME, a non-specific nitric oxide synthase inhibitor, on AlCl3-induced toxicity in the rat forebrain cortex. J Vet Sci (2009) 0.77